Literature DB >> 6246280

Site on the vesicular stomatitis virus genome specifying polyadenylation and the end of the L gene mRNA.

M Schubert, J D Keene, R C Herman, R A Lazzarini.   

Abstract

The 5'-terminal nucleotide sequence from positions 50 to 130 of vesicular stomatitis virus RNA was determined indirectly by using a defective interfering particle RNA which contains covalently linked genomic minus and antigenomic plus sense RNAs. The last 18 nucleotides of the L gene coding for in the viral polymerase were identified and isolated by specific duplex formation between 5' terminally labeled oligonucleotides from a small single-stranded defective interfering particle RNA and L gene mRNA. The L gene ends at position 60 from the 5' terminus of the vesicular stomatitis genome. The data demonstrated that the first seven adenine residues in the polyadenylic acid tail of L gene mRNA may be coded for in the genome and suggested that the viral transcriptase itself may carry out polyadenylation, possibly by chattering at the uridine-rich sequence at the end of the L gene. Analysis of the 5'-terminal sequence of vesicular stomatitis virus genomic RNA revealed that it might fold into a complex secondary structure with possibly 62% of the bases paired.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6246280      PMCID: PMC288735     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  Sequential transcription of the genes of vesicular stomatitis virus.

Authors:  G Abraham; A K Banerjee
Journal:  Proc Natl Acad Sci U S A       Date:  1976-05       Impact factor: 11.205

2.  5'-terminal sequence of vesicular stomatitis virus mRNA's synthesized in vitro.

Authors:  D P Rhodes; A K Banerjee
Journal:  J Virol       Date:  1975-01       Impact factor: 5.103

3.  Covalently linked message and anti-message (genomic) RNA from a defective vesicular stomatitis virus particle.

Authors:  R A Lazzarini; G H Weber; L D Johnson; G M Stamminger
Journal:  J Mol Biol       Date:  1975-09-25       Impact factor: 5.469

4.  Analysis of the RNA of defective VSV particles.

Authors:  G Stamminger; R A Lazzarini
Journal:  Cell       Date:  1974-09       Impact factor: 41.582

5.  Synthesis of poly(A) in vitro by purified virions of vesicular stomatitis virus.

Authors:  L P Villarreal; J J Holland
Journal:  Nat New Biol       Date:  1973-11-07

6.  Detection of homologous RNA sequences among six rhabdovirus genomes.

Authors:  P Repik; A Flamand; H F Clark; J F Obijeski; P Roy; D H Bishop
Journal:  J Virol       Date:  1974-01       Impact factor: 5.103

7.  In vitro synthesis of RNA that contains polyadenylate by virion-associated RNA polymerase of vesicular stomatitis virus.

Authors:  A K Banerjee; D P Rhodes
Journal:  Proc Natl Acad Sci U S A       Date:  1973-12       Impact factor: 11.205

8.  Serological relationships between different strains of vesicular stomatis virus.

Authors:  B Cartwright; F Brown
Journal:  J Gen Virol       Date:  1972-09       Impact factor: 3.891

9.  Synthesis of viral mRNA and polyadenylate by a ribonucleoprotein complex from extracts of VSV-infected cells.

Authors:  M F Murphy; R A Lazzarini
Journal:  Cell       Date:  1974-09       Impact factor: 41.582

10.  Order of transcription of genes of vesicular stomatitis virus.

Authors:  L A Ball; C N White
Journal:  Proc Natl Acad Sci U S A       Date:  1976-02       Impact factor: 11.205

View more
  50 in total

1.  Direct evidence that the poly(A) tail of influenza A virus mRNA is synthesized by reiterative copying of a U track in the virion RNA template.

Authors:  L L Poon; D C Pritlove; E Fodor; G G Brownlee
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

2.  The polyadenylation signal of influenza virus RNA involves a stretch of uridines followed by the RNA duplex of the panhandle structure.

Authors:  G X Luo; W Luytjes; M Enami; P Palese
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

3.  Increased readthrough transcription across the simian virus 5 M-F gene junction leads to growth defects and a global inhibition of viral mRNA synthesis.

Authors:  G D Parks; K R Ward; J C Rassa
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

4.  cis-Acting signals involved in termination of vesicular stomatitis virus mRNA synthesis include the conserved AUAC and the U7 signal for polyadenylation.

Authors:  J N Barr; S P Whelan; G W Wertz
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

5.  Polymerase slippage at vesicular stomatitis virus gene junctions to generate poly(A) is regulated by the upstream 3'-AUAC-5' tetranucleotide: implications for the mechanism of transcription termination.

Authors:  J N Barr; G W Wertz
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

6.  Transcription elongation complex stability: the topological lock.

Authors:  Xiaoqing Liu; Craig T Martin
Journal:  J Biol Chem       Date:  2009-10-21       Impact factor: 5.157

7.  Mutational analyses of the intergenic dinucleotide and the transcriptional start sequence of vesicular stomatitis virus (VSV) define sequences required for efficient termination and initiation of VSV transcripts.

Authors:  E A Stillman; M A Whitt
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

8.  The length and sequence composition of vesicular stomatitis virus intergenic regions affect mRNA levels and the site of transcript initiation.

Authors:  E A Stillman; M A Whitt
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

9.  Vesicular stomatitis virus mutants resistant to defective-interfering particles accumulate stable 5'-terminal and fewer 3'-terminal mutations in a stepwise manner.

Authors:  P J O'Hara; F M Horodyski; S T Nichol; J J Holland
Journal:  J Virol       Date:  1984-03       Impact factor: 5.103

10.  Transcriptional Regulation in Ebola Virus: Effects of Gene Border Structure and Regulatory Elements on Gene Expression and Polymerase Scanning Behavior.

Authors:  Kristina Brauburger; Yannik Boehmann; Verena Krähling; Elke Mühlberger
Journal:  J Virol       Date:  2015-12-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.